157 related articles for article (PubMed ID: 769952)
1. Combination chemotherapy for acute nonlymphoblastic leukemia in adults.
Glucksberg H; Buckner CD; Fefer A; DeMarsh Q; Coleman D; Dobrow RB; Huff J; Kjobech C; Hill AS; Dittman W; Neiman PE; Cheever MA; Einstein AB; Thomas ED
Cancer Chemother Rep; 1975; 59(6):1131-7. PubMed ID: 769952
[TBL] [Abstract][Full Text] [Related]
2. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6-thioguanine (NSC-752).
Armitage JO; Burns CP
Cancer Treat Rep; 1976 May; 60(5):585-9. PubMed ID: 991147
[TBL] [Abstract][Full Text] [Related]
4. Further local experience in the treatment of acute non-lymphoblastic leukaemia.
Bezwoda WR; Baynes RD; Hougaard M; Derman DP; Bothwell TH; Katz J
S Afr Med J; 1978 Dec; 54(24):1011-4. PubMed ID: 746438
[TBL] [Abstract][Full Text] [Related]
5. Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemia.
Cassileth PA; Kahn SB; Silber R; Weiler C
Cancer Clin Trials; 1981; 4(2):125-8. PubMed ID: 7249250
[TBL] [Abstract][Full Text] [Related]
6. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
Burns CP
Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
[No Abstract] [Full Text] [Related]
7. Proceedings: Treatment of acute leukaemia in adults.
Vincent PC; Gunz FW; Levi JA
Med J Aust; 1974 Jun; 1(26):1035-8. PubMed ID: 4527946
[No Abstract] [Full Text] [Related]
8. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
Presant CA; Berger NA; Klahr C; Phillips GL
Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Malpas J; Mathé G; Hayat M
Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
[No Abstract] [Full Text] [Related]
10. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
[TBL] [Abstract][Full Text] [Related]
11. Multiple-drug chemotherapy for acute leukemia The TRAMPCOL regimen: results in 86 patients.
Spiers AS; Goldman JM; Catovsky D; Costello C; Buskard NA; Galton DA
Cancer; 1977 Jul; 40(1):20-9. PubMed ID: 267503
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute leukemia in adults. Results with a combination of potent cytotoxic drugs.
Stavem P; Gjemdal T
Acta Med Scand; 1974; 196(1-2):121-5. PubMed ID: 4529548
[No Abstract] [Full Text] [Related]
13. High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adults.
Glucksberg H; Cheever MA; Farewell VT; Fefer A; Sale GE; Thomas ED
Cancer; 1981 Sep; 48(5):1073-81. PubMed ID: 7023650
[TBL] [Abstract][Full Text] [Related]
14. Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults.
Armitage JO; Burns CP; Dick FR; Aunan SB; Slymen DJ
Cancer Treat Rep; 1982 Nov; 66(11):1917-24. PubMed ID: 7139637
[TBL] [Abstract][Full Text] [Related]
15. The management of blastic crisis of chronic myeloid leukaemia with thioguanine, rubidomycin, ARA C and prednisone (TRAP regimen).
Resegotti L; Falda M; Rossi M; Infelise VE
Panminerva Med; 1973 Sep; 15(9):275-7. PubMed ID: 4533778
[No Abstract] [Full Text] [Related]
16. Treatment of acute myeloid leukaemia with daunorubicin, cytosine arabinoside, mercaptopurine, L-asparaginase, prednisone and thioguanine: results of treatment with five multiple-drug schedules. Report of the Medical Research Council's Working Party on Leukaemia in Adults.
Br J Haematol; 1974 Jul; 27(3):373-89. PubMed ID: 4607313
[No Abstract] [Full Text] [Related]
17. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
Cassileth PA; Katz ME
Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
[TBL] [Abstract][Full Text] [Related]
18. [Results of combined chemotherapy in treatment-resistant leukaemia of adults (author's transl)].
Bruntsch U; Osieka R; GAllmeier WM; Seeber S; Schmidt CG
Dtsch Med Wochenschr; 1975 Nov; 100(48):2478-82. PubMed ID: 1059536
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
[No Abstract] [Full Text] [Related]
20. Treatment of acute nonlymphocytic leukemia in elderly patients: a prospective study of intensive chemotherapy.
Peterson BA; Bloomfield CD
Cancer; 1977 Aug; 40(2):647-52. PubMed ID: 890652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
